Patents by Inventor Michael D. Cabelli

Michael D. Cabelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5814376
    Abstract: A method for detecting the presence of a specific analyte in a sample using an immunoassay format in which magnetic particles provide the solid phase and the signal is a dopant detectable by the change in conductivity of an electroconductive polymer coating an electrode. Additionally, magnetic devices for creating a strong force on the particles and the use of cacodylate to catalyze the production of a dopant, triiodide. Also, a gravure coating process for producing electroconductive polymer films.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 29, 1998
    Assignee: Ohmicron Medical Diagnostics, Inc.
    Inventor: Michael D. Cabelli
  • Patent number: 5547555
    Abstract: An electrochemical sensor cartridge with at least three reservoir cells, the floor of each cell in leakproof contact with the surface of an electrode assembly whose conductivity is affected by the presence of an analyte in that cell.
    Type: Grant
    Filed: February 22, 1993
    Date of Patent: August 20, 1996
    Assignee: Ohmicron Technology, Inc.
    Inventors: Jerome L. Schwartz, Michael D. Cabelli, John C. Silvia, Craig D. T. Dahlin
  • Patent number: 4397779
    Abstract: Compounds useful as tracers in the radioimmunoassay of xanthine derivatives such as theophylline and pharmacologically related drugs: ##STR1## wherein at least one R.sub.1, R.sub.3, R.sub.7 or R.sub.8 is a radioiodinated radical and wherein, if not substituted by a radioiodinated radical, the remaining R.sub.1, R.sub.3, R.sub.7 or R.sub.8 groups are otherwise identical to the substituents at these positions in the xanthine derivative to be assayed. Ordinarily, R.sub.1 is hydrogen, acetate or methyl; R.sub.3 is methyl; R.sub.7 is hydrogen, acetate or methyl; and R.sub.8 is hydrogen. The tracers are made by linking radioiodinatable or preradioiodinated radicals to the xanthine derivative which is to be assayed. The tracers may be employed in known radioimmunoassay techniques.
    Type: Grant
    Filed: May 28, 1981
    Date of Patent: August 9, 1983
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventors: Ernest V. Groman, Michael D. Cabelli
  • Patent number: 4332786
    Abstract: The binding of vitamin B-12 by natural substances in samples assayed for vitamin B-12 is reduced by heating the test sample in an alkaline buffer comprising thioglycerol and denaturing agent having the formula (R).sub.2 NC(A)N(R).sub.2, wherein R is hydrogen or lower alkyl and A is oxygen or hydroxyl.
    Type: Grant
    Filed: May 15, 1980
    Date of Patent: June 1, 1982
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventors: Michael D. Cabelli, Ernest V. Groman
  • Patent number: 4297494
    Abstract: Compounds useful as tracers in the radioimmunoassay of xanthine derivatives such as theophylline and pharmacologically related drugs: ##STR1## Wherein at least one R.sub.1, R.sub.3, R.sub.7 or R.sub.8 is a radioiodinated radical and wherein, if not substituted by a radioiodinated radical, the remaining R.sub.1, R.sub.3, R.sub.7 or R.sub.8 groups are otherwise identical to the substituents at these positions in the xanthine derivative to be assayed. Ordinarily, R.sub.1 is hydrogen, acetate or methyl; R.sub.3 is methyl; R.sub.7 is hydrogen, acetate or methyl; and R.sub.8 is hydrogen. The tracers are made by linking radioiodinatable or preradioiodinated radicals to the xanthine derivative which is to be assayed. The tracers may be employed in known radioimmunoassay techniques.
    Type: Grant
    Filed: August 9, 1978
    Date of Patent: October 27, 1981
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventors: Ernest V. Groman, Michael D. Cabelli